Tyrosine kinase inhibitors and signal transduction modulators: Rationale and current status as chemopreventive agents for prostate cancer

Raymond C. Bergan, Doyle H. Waggle, Stephen K. Carter, Ivan Horak, William Slichenmyer, Michael Meyers

Research output: Contribution to journalArticlepeer-review

22 Scopus citations

Fingerprint

Dive into the research topics of 'Tyrosine kinase inhibitors and signal transduction modulators: Rationale and current status as chemopreventive agents for prostate cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences